BCL6 promotes the progression of high-grade serous ovarian cancer cells by inhibiting PLAAT4
Collectively, these findings elucidate the pivotal role of the BCL6-PLAAT4-AKT axis in HGSOC progression, establishing a molecular framework for targeting this pathway as a potential therapeutic strategy against HGSOC.
Authors
- Jin‐Hui Tao (ORCID: https://orcid.org/0000-0003-4904-033X)
- An Wan
- Gang Chen (ORCID: https://orcid.org/0000-0002-8320-6594)
- Weidong Zhao (ORCID: https://orcid.org/0000-0001-8135-7279)
Institutions
- University of Science and Technology of China (CN)
- Anhui University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3389/fphar.2025.1634995
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundamental Research Funds for the Central Universities